State DC
Clinical Trials in Washington D.C.
Recruiting clinical trials with at least one study location in Washington D.C.. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington D.C.
Malignant Solid Neoplasm (5)Alzheimer Disease (4)Prostate Cancer (3)Solid Tumor (3)Ewing Sarcoma (3)Hepatocellular Carcinoma (3)Myeloproliferative Neoplasm (2)Acute Treatment of Migraine (2)Asthma in Children (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Lymphoblastic Leukemia (2)Acute Myeloid Leukemia (2)
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Condition
High Grade Glioma
Enrollment
60 pts
Location
United States, Australia, Canada
Sponsor
Rigel Pharmaceuticals
NCT03822442 N/A
Recruiting
MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients
Condition
Heart Failure
Enrollment
200 pts
Location
United States
Sponsor
Children's National Research I
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06275360 Phase 2
Recruiting
Repositioning Immunotherapy in VetArans With Lung Cancer
Condition
Non-Small Cell Lung Cancer
Enrollment
25 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT04965675 Phase 3
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Condition
Chronic Migraine in Children
Enrollment
285 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT05966311 N/A
Recruiting
Pediatric Percutaneous Ultrasound Gastrostomy Technique
Condition
Gastrostomy
Enrollment
80 pts
Location
United States
Sponsor
CoapTech
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastati...
Condition
Autoimmune Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT04855773 N/A
Recruiting
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP...
Condition
HIV Infections
Enrollment
300 pts
Location
United States
Sponsor
Public Health Foundation Enter
NCT02935283 N/A
Recruiting
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
Condition
Urea Cycle Disorders
Enrollment
56 pts
Location
United States
Sponsor
Children's National Research I
NCT04665739 Phase 2
Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive...
Condition
Advanced Lung Neuroendocrine Tumor
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03507257 N/A
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Condition
Early Onset Alzheimer Disease
Enrollment
850 pts
Location
United States, Argentina, Netherlands
Sponsor
Indiana University
NCT07390591 N/A
Recruiting
Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Sym...
Condition
Spinal Cord Injuries
Enrollment
60 pts
Location
United States
Sponsor
Medstar Health Research Instit
NCT06118515 Phase 1
Recruiting
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cy...
Condition
Congenital Cytomegalovirus Infection
Enrollment
12 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, Japan, United Kingdom
Sponsor
Stoke Therapeutics, Inc
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05440708 Phase 1, Phase 2
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locall...
Condition
Hepatocellular Carcinoma
Enrollment
178 pts
Location
United States
Sponsor
Tvardi Therapeutics, Incorpora
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT05010603 N/A
Recruiting
Late Onset Alzheimer's Disease
Condition
Alzheimer Disease
Enrollment
10,000 pts
Location
United States
Sponsor
Columbia University
NCT07007559 Phase 1, Phase 2
Recruiting
ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Adv...
Condition
Breast Cancer, Metastatic
Enrollment
80 pts
Location
United States
Sponsor
ALX Oncology Inc.
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene